The effects of tobacco smoking on gastric motility in patients with duodenal ulcer.

A. Kay

Abstract:

What problem does this paper attempt to address?

A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia–Induced Hypotension During Cesarean Delivery

Fei Xiao,Changna Wei,Xiangyang Chang,Yinfa Zhang,Lili Xue,Huaxiang Shen,Warwick D. Ngan Kee,Xinzhong Chen

DOI: https://doi.org/10.1213/ane.0000000000004534

2019-01-01

Abstract:BACKGROUND: Ondansetron has been shown to reduce the incidence of hypotension and vasopressor requirement during spinal anesthesia for obstetric and nonobstetric surgery. However, the magnitude of this effect has not been fully quantified. In this parallel-group, randomized, double-blinded study, we determined the effective dose in 50% of subjects (ED50) of a prophylactic phenylephrine infusion for preventing hypotension in patients who received a single dose of intravenous ondansetron 4 mg or saline control before combined spinal–epidural anesthesia for elective cesarean delivery. ED50 values obtained were compared to estimate the effect of ondansetron versus placebo on vasopressor requirement. METHODS: Sixty parturients were randomly assigned to receive ondansetron (group O) or saline control (group C) 10 minutes before positioning for induction of spinal anesthesia. A prophylactic phenylephrine infusion was used to prevent hypotension. The first patient in each group received a phenylephrine infusion at the rate of 0.5 µg/kg/min. The infusion rate for each subsequent patient was varied with increments or decrements of 0.05 µg/kg/min based on the response of the previous patient, and the effective dose of the phenylephrine infusion for preventing hypotension in 50% of patients (ED50) was calculated for each group and compared using up-down sequential analysis. Probit regression was applied as a backup and sensitivity analysis was used to compare ED50 values for phenylephrine between groups by comparing calculated relative mean potency. RESULTS: The ED50 (mean [95% confidence interval (CI)]) of the rate of phenylephrine infusion was lower in group O (0.24 µg/kg/min [0.10–0.38 µg/kg/min]) compared with group C (0.32 µg/kg/min [0.14–0.47 µg/kg/min]) (P < .001). The total consumption of phenylephrine (mean ± standard deviation [SD]) until delivery was lower in group O (316.5 ± 25.9 µg) than in group C (387.7 ± 14.7 µg, P = .02). The estimate of relative median potency for phenylephrine for group O versus group C was 0.74 (95% CI, 0.37–0.95). CONCLUSIONS: Under the conditions of this study, intravenous ondansetron 4 mg reduced the ED50 of a prophylactic phenylephrine infusion by approximately 26% in patients undergoing cesarean delivery under combined spinal–epidural anesthesia.
Comparative Dose-Response Study of Phenylephrine Bolus for the Treatment of the First Episode of Spinal Anesthesia-Induced Hypotension for Cesarean Delivery in Severe Preeclamptic Versus Normotensive Parturients

Li-Juan Hu,Zhong Mei,Yan-Ping Shen,Hao-Tian Sun,Zhi-Min Sheng,Xin-Zhong Chen,Xiao-Wei Qian

DOI: https://doi.org/10.2147/dddt.s368480

IF: 4.3188

2022-01-01

Drug Design Development and Therapy

Abstract:Background It is well-known that severe preeclamptic parturients have less vasopressor requirements than normotensive parturients; however, the exact dose difference is poorly documented. This study aimed to determine and compare the ED50 and ED90 of a single bolus phenylephrine for the treatment of spinal anesthesia-induced hypotension in parturients with severe preeclampsia and parturients with normotension. Methods Seventy-five parturients with severe preeclampsia scheduled for cesarean delivery under combined spinal-epidural anesthesia were enrolled and randomly allocated to receive a single bolus of phenylephrine at five different doses (40, 50, 60, 70, and 80 μg), whereas 75 parturients with normotension were randomized to receive a single bolus of phenylephrine at five different doses (70, 80, 90, 100, and 110 μg) for the treatment of the first episode of hypotension. Phenylephrine dose values were log-transformed, the proportions of the successful interventions at each dose were converted to probits, and regression analysis was performed. Results The ED50 and ED90 (95% CI) of bolus phenylephrine were 72.1 (61.7 to 79.9) μg and 107 (95.9–128.6) μg in parturients with normotension. The ED50 and ED90 values in parturients with severe preeclampsia were 47.6 (41.3–52.7) μg and 70.7 (62.9–86.7) μg. The relative median potency was 1.51 (1.16–2.61). Conclusion Under this study conditions, severe preeclamptic parturients required a 34% reduction of ED50 of phenylephrine dose compared with normotensive parturients.
128: THE EFFECT OF INTRAMUSCULAR HYOSCINE AND HYOSCINE-PROMETHAZINE ON THE DURATION OF LABOR IN NULLIPAROUS PREGNANT WOMEN (TRIPLE-BLIND RANDOMIZED CONTROLLED TRIAL)

Fahimeh Sehhatie Shafahi,Farzeneh Shahmohammadi,Fatemeh Khanmohammadi,Mohamad Ashari Jaffarabadi

DOI: https://doi.org/10.1136/bmjopen-2016-015415.128

IF: 3.006

2017-02-01

BMJ Open

Abstract:Background and aims: Improvement of maternal healthiness and decreasing maternal mortality and morbidity is one of important anxieties in the world. One of the factors that influence intensity of pain is duration of labor. In other words, increasing intensity of pain affects duration of labor. This study survey the effect of intramuscular Hyoscine and Hyoscine-Promethazine on the duration of labor in nulliparous pregnant women. Methods: This study was three blind clinical trials on 213 nulliparous pregnant women who have referred to Amiralmomenin hospital in Zanjan. Selection of samples was random and done with Rand List software and used 3, 6 (1:1:1) of blocking size. This study had 3 groups. First group received 20 mg Hyoscine(A), second group 20mg Hyoscine and 25mg Promethazine(B) and third group 3cc sterile water(C). Data collection tools were including of a demographic questionnaire, checklist of data and Partograph chart. Analysis of data done by SPSS (ver16) and Anova (tukey) and chi-square test. Results: Means of first stage of labor in Hyoscine group was 88.95±51.07 min, Hyoscine-Promethazine 100.05±65.88 min and control group 170.37±106.87 min. there is significant correlation between A,C and B, C groups (p<0.001). second stage means in group A was 46.37±44.60, group B 32.25±17.74 and control group 55.05±44.44 and significant relationship was between B,C groups(p=0.03) . In third stage no significant difference observed between groups (p=0.105). Conclusion: Sometimes and in some urgency cases, for decreasing duration of labor, we can use Hyoscine and Hyoscine-Promethazine.

medicine, general & internal
Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis

Hanglin Wu,Songying Zhang,Xiaona Lin,Jing He,Shasha Wang,Ping Zhou

DOI: https://doi.org/10.1186/s12958-021-00846-6

2021-01-01

Reproductive Biology and Endocrinology

Abstract:Background Progesterone supplementation is widely performed in women with threatened miscarriage or a history of recurrent miscarriage; however, the effects of early progesterone supplementation on pregnancy-related complications and perinatal outcomes in later gestational weeks remain unknown. Methods Ovid MEDLINE, the Cochrane Library, Embase and ClinicalTrials.gov were searched until April 3rd, 2021. Randomized controlled trials regarding spontaneously achieved singleton pregnancies who were treated with progestogen before 20 weeks of pregnancy and were compared with those women in unexposed control groups were selected for inclusion. We performed pairwise meta-analyses with the random-effects model. The risk of bias was assessed according to the Cochrane Collaboration tool. The primary outcomes included preeclampsia (PE), and gestational diabetes mellitus (GDM), with the results presented as odds ratios (ORs) with 95% confidence intervals (CIs). Results We identified nine eligible studies involving 6439 participants. The pooled OR of subsequent PE following early progestogen supplementation was 0.64 (95% CI 0.42–0.98, moderate quality of evidence). A lower OR for PE was observed in the progestogen group when the subgroup analysis was performed in the vaginal subgroup (OR 0.62, 95%CI 0.40–0.96). There was insufficient evidence of a difference in the rate of GDM between pregnant women with early progestogen supplementation and unexposed pregnant women (OR 1.02, 95% CI 0.79–1.32, low quality of evidence). The pooled OR of low birth weight (LBW) following oral dydrogesterone was 0.57 (95% CI 0.34–0.95, moderate quality of evidence). The results were affected by a single study and the total sample size of enrolled women did not reach the required information size. Conclusion Use of vaginal micronized progesterone (Utrogestan) in spontaneously achieved singleton pregnancies with threatened miscarriage before 20 weeks of pregnancy may reduce the risk of PE in later gestational weeks. Among spontaneously achieved singleton pregnancies with threatened miscarriage or a history of recurrent miscarriage, use of oral dydrogesterone before 20 weeks of pregnancy may result in a lower risk of LBW in later gestational weeks. However, the available data were not sufficient to reach definitive conclusions, which highlighted the need for future studies.
Effect of Ephedrine Combined with Bupivacaine on Maternal Hemodynamic and Spinal Nerve Block in Cesarean Delivery

Mingyue Ge,Sheng Wang,Zhigang Dai,Yan Li,Liping Xie,Xuejao Liu,Jiangwen Yin

DOI: https://doi.org/10.3892/br.2017.846

2017-01-01

Biomedical Reports

Abstract:The aim of the study was to investigate the effects of ephedrine intrathecal injection on maternal thermodynamics and spinal nerve block in cesarean section. A total of 107 patients undergoing elective cesarean section under combined spinal epidural anesthesia were randomly divided into two groups: group E: Bupivacaine (6 mg) combined with ephedrine (15 mg) and group C: Bupivacaine (6 mg). Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), the incidence of hypotension, hypertension, tachycardia, nausea and vomiting were all recorded. The umbilical vein blood gases and noradrenaline, as well as maternal peripheral venous blood were analyzed. The time of high-quality spinal block was also recorded. Postoperatively, 1 day, 2 days bedside follow-up and 7, 21, 35 days telephone follow-up were carried out to determine any neurological deficit maternal performance. SBP and DBP decreased in group C but not in group E at 3 min after spinal anesthesia and 1 min after delivery (P<0.05). From 3 min post-anesthesia to the end of surgery, the HR levels in the C group were significantly higher than those of the E group (P<0.05). The incidence of hypotension, tachycardia, nausea and vomiting and neonate acidosis was low in group E compared with group C (P<0.05). The time of high-quality spinal block in group E was longer than that of group C (P<0.05). After spinal anesthesia, the concentration of noradrenaline from maternal peripheral venous blood was low in group C but high in group E compared with before spinal anesthesia (P<0.05). Ephedrine combined with low-dose bupivacaine intrathecal injection effectively maintained maternal hemodynamics and prolonged the time of sensory spinal block.
Comparing the effect of intravenous dexamethasone, intravenous ondansetron, and their combination on nausea and vomiting in cesarean section with spinal anesthesia

Shahryar Sane,Mohammadamin Valizadeh Hasanlui,Rahman Abbasivash,Alireza Mahoori,Seyed Taghi Hashemi,Fahime Rafiei,MohammadaminValizadeh Hasanlui,SeyedTaghi Hashemi,Sharyar Sane,Rahman Abbasi

DOI: https://doi.org/10.4103/2277-9175.167030

2015-01-01

Advanced Biomedical Research

Abstract:BACKGROUND: Nausea and vomiting are frequently seen in patients undergoing cesarean section (CS) under regional anesthesia. We aimed to compare the antiemetic efficacy of ondansetron and dexamethasone combination with that of the use of each agent alone to decrease the incidence of postdelivery intra- and post-operative nausea and vomiting during CS under spinal anesthesia.MATERIALS AND METHODS: A randomized, prospective, double-blind study was performed on 90 patients undergoing planned CS under spinal anesthesia. The patients received 4 mg ondansetron in Group O, 8 mg dexamethasone in Group D, and 4 mg ondansetron +8 mg dexamethasone in Group OD intravenously within 1-2 min after the umbilical cord was clamped. Frequency of postdelivery intra- and post-operative nausea and vomiting episodes was recorded.RESULTS: A total of 90 eligible patients were included in the study. There were 30 patients in Group O, 30 patients in Group D, and 30 patients in Group OD. Intraoperative nausea in Group D was more than the other two groups. Postoperative nausea in group OD was lesser than the other two groups. Intraoperative vomiting in Group OD was lesser than the other two groups. There was no statistically significant difference among the groups in postoperative vomiting (P > 0.05).CONCLUSION: Combined use of dexamethasone and ondansetron for the same indication seems to increase the antiemetic efficacy.

English Else
Comparing the Effectiveness of Ondansetron and Dexamethasone on Nausea/Vomiting in Cesarean Section under Spinal Anesthesia

DOI: https://doi.org/10.36283/pjmd11-2/003

2022-04-14

Pakistan Journal of Medicine and Dentistry

Abstract:Background: Nausea and vomiting are frequently witnessed for pregnant women who undergo C-sections under spinal anesthesia. The objective of this study was to determine the effectiveness of Ondansetron and Dexamethasone on nausea and vomiting in patients undergoing spinal anesthesia for cesarean section. Methods: This was an experimental study conducted in the Department of Anesthesia and Department of Obstetrics and Gynecology, Hamdard University Hospital, from April 15, 2021-August 15, 2021. Pregnant women (n=93) with the age >18- 0.05). Post-operative 11(22.0%) cases reported nausea and 1.0(2.0%) cases of vomiting in the dexamethasone group with significant difference (p=0.001), however, participants of the Ondansetron group did not report any symptom. Conclusion: Ondansetron 4mg/kg dose decreased the propensity of nausea and vomiting after cesarean section. However, dexamethasone 8mg/kg seemed to be effective in controlling postoperative vomiting only. Keywords: Nausea; Vomiting; Ondansetron; Dexamethasone; Spinal Anesthesia.

English Else
Adjuvant Treatment with Oral Dydrogesterone in the Prevention of Preterm Labor: A Randomized, Double-Blinded, Placebo-Controlled Trial

Hengameh Keshtmandi,Majid Mirmohammadkhani,Mojgan Rahmanian

DOI: https://doi.org/10.1007/s43032-023-01249-1

Abstract:We conducted a double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy of oral dydrogesterone (DG) on maternal and neonatal consequences in the treatment of preterm labor. We included 100 nulliparous mothers (24-34 weeks) with normal pregnancy who had preterm labor pain. Participants who received magnesium sulfate were randomly assigned to the investigation group (DG 30 mg/day) or placebo group. Maternal and neonatal outcomes were compared between the two groups. Recurrent uterine contraction (UC) rates (92% vs. 88%, P = 0.862) and the incidence of preterm delivery (66% vs. 58%, P = 0.834) were not different in the DG and placebo groups. No significant differences were observed in terms of gestational age at delivery (33.5 ± 3.5 vs. 34.2 ± 3.2, P = 0.281), latency period (5.53 ± 2.29 days vs. 5.59 ± 2.57 days, P = 0.622), cervical dilation (1.82 ± 0.26 cm vs. 1.84 ± 0.29 cm, P = 0.281), and effacement (53 ± 4.47% vs. 57.21 ± 6.27%, P = 0.622) between the placebo and DG groups. The percentage of neonates with a 1-min Apgar score < 7 was higher in the placebo group compared with that of the DG group (12% vs. 0%, P = 0.0001). However, both groups were similar in the frequency of a 5-min Apgar score < 7. No differences in the term of adverse effects of medications were recorded. Our results showed that DG adjuvant to magnesium sulfate could not be effective in improving the incidence of preterm labor, rate of recurrent UC, latency period, pregnancy outcomes, and maternal and neonatal outcomes when compared with the placebo group.
EFFECT OF LIDOCAINE ON CERVICAL MUCOSAL ABSORPTION ON LABOR PROGRESS AND EVALUATION OF ITS EFFECT

Zhang Lin,Huang Jianxia,Wu Hanglin,Song Weinv

DOI: https://doi.org/10.19193/0393-6384_2019_3_196

2019-01-01

Acta medica mediterranea

Abstract:Objective: To observe the effect of lidocaine transcervical mucosal absorption on labor progression and maternal and fetal outcomes. Methods: A total of 228 healthy pregnant women who gave birth in our hospital from January 2017 to May 2018 were enrolled and divided into the A, B, and C groups according to a random number table, with 76 cases in each group. Group A was treated with lidocaine cervical wet compressing; Group B was treated with lidocaine cervical injection; Group C was the control Group And thus, was not treated. The first stage of labor time, the cervical swelling rate, uterine dilatation rate, the Apgar score at 1 minute and 5 minutes after birth, postpartum hemorrhage, neonatal asphyxia and cervical laceration were observed in the three groups. Further, adverse reactions such as nausea, vomiting, sweating and palpitation were recorded in the three groups during the medication. Results: In Group A and Group B, during the first stage of labor time, cervical swelling rate at 2 h after treatment and uterine dilatation rate at 2 h after treatment, were significantly better than those in Group C (P<0.05). However, there was no significant difference between Group A and Group B (P>0.05). Moreover, there was no significant difference in Apgar score at I min after birth and 5 min after birth and neonatal asphyxia rate among the three groups (P>0.05). The number of cervical lacerations during labor progress in Group A was significantly lower than that in Group C (p<0.05). As well, the number of cases of cervical laceration in Group A was lower than that in Group B, and the difference was statistically significant (p<0.05). Lastly, there was no significant difference in the incidence of adverse reactions among the three groups during the period of medication (p>0.05). Conclusion: Lidocaine can soften the cervix and shorten the first stage of labor through cervical wet compressing and cervical injection. It has no adverse effect on maternal and infant outcomes and also has higher safety levels. Compared with cervical wet compressing, the cervical laceration rate by cervical injection is higher, so attention should be paid in the course of clinical application.
The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial

Lise Christine Gaudernack,Angeline Elisabeth Styve Einarsen,Ingvil Krarup Sørbye,Mirjam Lukasse,Nina Gunnes,Trond Melbye Michelsen

DOI: https://doi.org/10.1371/journal.pmed.1004352

2024-03-29

PLoS Medicine

Abstract:Prolonged labor is a common condition associated with maternal and perinatal complications. The standard treatment with oxytocin for augmentation of labor increases the risk of adverse outcomes. Hyoscine butylbromide is a spasmolytic drug with few side effects shown to shorten labor when used in a general population of laboring women. However, research on its effect on preventing prolonged labor is lacking. We aimed to assess the effect of hyoscine butylbromide on the duration of labor in nulliparous women showing early signs of slow labor. In this double-blind randomized placebo-controlled trial, we included 249 nulliparous women at term with 1 fetus in cephalic presentation and spontaneous start of labor, showing early signs of prolonged labor by crossing the alert line of the World Health Organization (WHO) partograph. The trial was conducted at Oslo University Hospital in Norway from May 2019 to December 2021. One hundred and twenty-five participants were randomized to receive 1 ml hyoscine butylbromide (Buscopan) (20 mg/ml), while 124 received 1 ml sodium chloride intravenously. Randomization was computer-generated, with allocation concealment by opaque sequentially numbered sealed envelopes. The primary outcome was duration of labor from administration of the investigational medicinal product (IMP) to vaginal delivery, which was analyzed by Weibull regression to estimate the cause-specific hazard ratio (HR) of vaginal delivery between the 2 treatment groups, with associated 95% confidence interval (CI). A wide range of secondary maternal and perinatal outcomes were also evaluated. Time-to-event outcomes were analyzed by Weibull regression, whereas continuous and dichotomous outcomes were analyzed by median regression and logistic regression, respectively. All main analyses were based on the modified intention-to-treat (ITT) set of eligible women with signed informed consent receiving either of the 2 treatments. The follow-up period lasted during the postpartum hospital stay. All personnel, participants, and researchers were blinded to the treatment allocation. Median (mean) labor duration from IMP administration to vaginal delivery was 401 (440.8) min in the hyoscine butylbromide group versus 432.5 (453.6) min in the placebo group. We found no statistically significant association between IMP and duration of labor from IMP administration to vaginal delivery: cause-specific HR of 1.00 (95% CI [0.77, 1.29]; p = 0.993). Among 255 randomized women having received 1 dose of IMP, 169 women (66.3%) reported a mild adverse event: 75.2% in the hyoscine butylbromide group and 57.1% in the placebo group (Pearson's chi-square test: p = 0.002). More than half of eligible women were not included in the study because they did not wish to participate or were not included upon admission. The participants might have represented a selected group of women reducing the external validity of the study. One intravenous dose of 20 mg hyoscine butylbromide was not found to be superior to placebo in preventing slow labor progress in a population of first-time mothers at risk of prolonged labor. Further research is warranted to answer whether increased and/or repeated doses of hyoscine butylbromide might have an effect on duration of labor. ClinicalTrials.gov (NCT03961165) EudraCT (2018-002338-19)

medicine, general & internal
Effects of dicaine, valium combined anisodamine in induced labor of term pregnancy

Bei WANG,Hai-Dong CHENG

DOI: https://doi.org/10.3969/j.issn.1001-4411.2007.04.019

2007-01-01

Abstract:Objective:To explore the effects of dicaine, valium and anisodamine jointly used in induced labor of term pregnancy.Methods:Dicaine,valium and anisodamine jointly were used in 60 cases, valium and anisodamine jointly used in 50 cases, and oxytocin only used in 46 cases to analyze and compare the data of three groups.Results:Using dicaine, valium and anisodamine jointly shortened the first stage of labor significantly (P<0.01) and the apgar score of neonate, the rate of forceps and the postpartum hemorrhage were not significantly different in statistics among 3 groups (P>0.05).Conclusion:Dicaine, valium and anisodamine is valid inducing labor method in term pregnancies to promote labor process.
Cost-effectiveness of clozapine therapy for severe psychosis.

S. Ghaemi,D. Ziegler,T. Peachey,F. Goodwin

DOI: https://doi.org/10.1176/PS.49.6.829

1998-06-01

Psychiatric Services

Abstract:The cost-effectiveness of using the atypical antipsychotic medication clozapine for severe psychosis was examined in a rural public-sector community mental health setting in Virginia. Based on a sample of 20 patients, use of clozapine resulted in estimated cost savings of between $3,000 and $9,000 per patient per year, including the costs of dropouts from treatment. Savings were mainly due to a decline in hospitalization from 47.7+/-59.8 days per patient in the year before clozapine treatment to 4.6+/-11.3 days in the year after. Although this study had methodological limitations, the results suggest that clozapine may be cost-effective in this setting.
Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4.

T. Yoshimoto,Albert Bendelac,J. Hu‐Li,W. E. Paul

DOI: https://doi.org/10.1073/PNAS.92.25.11931

1995-12-05

Abstract:SJL mice produce little or no IgE in response to polyclonal stimulation with anti-IgD antibody and fail to express interleukin 4 (IL-4) mRNA in the spleen 5 days after injection of anti-IgD, in contrast to other mouse strains that produce substantial amounts of IgE and IL-4. Because IL-4 is critical in IgE production, the possibility that SJL mice are poor IgE producers because their naive T cells fail to differentiate into IL-4 producers must be seriously considered. IL-4 itself is the principal factor determining that naive T cells develop into IL-4 producers. A major source of IL-4 for such differentiation is a population of CD1-specific CD4+ T cells that express NK1.1. These cells produce IL-4 within 90 min of anti-CD3 injection. T cells from SJL mice fail to produce IL-4 in response to injection of anti-CD3. Similarly, SJL T cells and CD4+ thymocytes do not produce IL-4 in response to acute in vitro stimulation. SJL T cells show a marked deficiency in CD4+ cells that express the surface receptors associated with the NK1.1+ T-cell phenotype. This result indicates that the SJL defect in IgE and IL-4 production is associated with, and may be due to, the absence of the CD4+, NK1.1+ T-cell population.
Comparison of the Prophylactic Effect of Propofol, Dexamethasone and Ondansetron on Post-Operative Nausea and Vomiting in Elective Cesarean Section Under Spinal Anesthesia

Ebrahim Hassani,Nazli Karami,Asma Hassani,Leila Hassani,Veghar Ashraf

DOI: https://doi.org/10.18502/acta.v59i12.8059

2021-12-17

ACTA MEDICA IRANICA

Abstract:Nausea, and vomiting are common complications in women undergoing cesarean section with spinal anesthesia. This study aimed to compare the propofol, dexamethasone, and ondansetron effects on nausea and vomiting. In this double-blind, randomized clinical trial study, 120 women aged 15 to 35 years candidates for cesarean section under spinal anesthesia were enrolled. Patients were randomly divided into four groups (three-drug groups and control group). Patients received 0.05 mg/kg ondansetron (group O), 0.1 mg/kg dexamethasone (group D), 0.2 mg/kg propofol (group P) and normal saline in controls (group C). Nausea and vomiting in recovery and 6 hours after surgery compared between groups. In recovery and 6 hours after surgery, both nausea and vomiting were the highest in group C while they were lowest in group O. the frequency of nausea was 11(36.7%) in both recovery and 6 hours after surgery, and the frequency of vomiting was 12(40%) and 10(33.3%) in the recovery and 6 hours after surgery respectively. Among three drug groups, nausea and vomiting were higher in group D in both the recovery room and 6 hours after surgery. The frequency of vomiting was 10 (33.3%) and 5 (16.7%) in recovery and 6 hours after surgery in group D, respectively. These differences were statistically significant between the four groups (P<0.05). The preventive effect of dexamethasone is not very useful in both periods. Therefore, it can be recommended that in the short period after surgery, propofol has a beneficial effect in preventing postoperative nausea and vomiting.

English Else
Efficacy of dexmedetomidine in suppressing cardiovascular and hormonal responses to general anaesthesia for caesarean delivery: a dose-response study

M R El-Tahan,H A Mowafi,I H Al Sheikh,A M Khidr,R A Al-Juhaiman

DOI: https://doi.org/10.1016/j.ijoa.2012.04.006

Abstract:Background: Preoperative dexmedetomidine administration blunts haemodynamic and hormonal responses to tracheal intubation and reduces anaesthetic requirements. We hypothesized that dexmedetomidine would reduce the maternal haemodynamic and hormonal responses to elective caesarean delivery without harmful neonatal effects. Methods: After ethical approval, 68 parturients scheduled for elective caesarean delivery under general anaesthesia were randomly allocated to receive either placebo, or 0.2, 0.4 or 0.6 μg/kg/h intravenous dexmedetomidine (n=17 per group) 20 min before induction. Anaesthesia was induced using a rapid-sequence technique with propofol and suxamethonium, and was maintained with 0.5-0.75 minimum alveolar concentration sevoflurane. Changes in maternal heart rate, mean blood pressure, minimum alveolar concentration sevoflurane, uterine tone, serum cortisol level, and Apgar scores, Neurologic Adaptive Capacity Scores and acid-base status were recorded. Results: After induction, patients receiving dexmedetomidine had smaller increases in heart rate (P<0.001) than those in the placebo group. Patients who received 0.4 and 0.6 μg/kg/h infusions of dexmedetomidine showed slower heart rates (-21.5% and -36%, respectively; P<0.001), lower mean blood pressures (-17% and -25%, respectively; P<0.001), sevoflurane minimum alveolar concentrations (-40% and -44.5%, respectively; P<0.001) and serum cortisol levels (-27% and -34.6%, respectively; P<0.001) and higher sedation scores for the first 15 min after extubation and greater uterine tone (P<0.002). Apgar scores, NACS and acid-base status were similar in the four groups. Conclusion: Preoperative administration of dexmedetomidine 0.4 and 0.6 μg/kg/h is effective in attenuating the maternal haemodynamic and hormonal responses to caesarean delivery under sevoflurane anaesthesia without adverse neonatal effects.
Comparing prophylactic effect of dexamethasone alone Vs combination of dexamethasone and ondansetron on nausea and vomiting in pregnant women undergoing cesarean section: A systematic review and meta-analysis of published randomized controlled trials

Mohamed Elgazzar,Mohamed E. ElHodiby,Ali Bendary,Yehya Dabour

DOI: https://doi.org/10.21608/bmfj.2023.152946.1628

2023-02-03

Benha Medical Journal

Abstract:The efficacy of dexamethasone and ondansetron on intra and post operative nausea and vomiting is confusing and still debatable. We conducted this systematic review and meta-analysis to synthesize evidence from published studies on the efficacy and the impact of dexamethasone and ondansetron for cutting the risk of nausea and vomiting in pregnant women. We followed the standard methods of the Cochrane Handbook of Systematic Reviews for interventions and the PRISMA statement guidelines 2020 when conducting and reporting this study. A computer literature search of PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials conducted from inception until January 2022. We selected randomized controlled trials (RCTs) assessing the efficacy of dexamethasone alone Vs combination of dexamethasone and ondansetron on nausea and vomiting in pregnant women undergoing cesarean section, and all relevant outcomes were pooled in the meta-analysis using Review Manager Software. five RCTs were included in our study with only four RCTs included in the meta-analysis. The pooled risk ratio suggested that there is no significant difference between Ondansetron and combination or dexamethasone in reducing pre-operative vomiting as following respectively:[RR=1.9,95%CI(0.164,22.2),P= 0.605], and [RR=0.549, 95%CI (0.160,1.882), P=0.17]. Also, regarding pre-operative nausea there is no significant difference between ondansetron and combination or between dexamethasone and combination as following;[RR=0.7,95%CI(0.3,1.64),P=0.41],and[RR=1.91,95%CI(0.98,3.71),P=0.06]. while combination intervention reduces the incidence of post-operative nausea and vomiting compared to both ondansetron and dexamethasone as following respectively:[RR=2.44,95%CI(1.28,4.63),P=0.007],and[RR=7.29,95%CI(2.46,21.54),P= 0.0003]. Combination of dexamethasone and ondansetron reduce intra operative vomiting and post operative nausea and vomiting.

English Else
The Use of Evening Primrose Oil for Cervical Ripening in Low-Risk Women with Term Pregnancy: A Randomized Double-Blinded Controlled Trial

Shideh Ariana,Nooshin Amjadi,Seyyedeh Neda Kazemi,Zahra Ahmadli

DOI: https://doi.org/10.1159/000535585

2024-02-20

Complementary Medicine Research

Abstract:Background: Several methods have been developed for cervical ripening. The data regarding the efficiency of evening primrose oil (EPO) are inconsistent. The purpose of this study is to investigate the outcomes of EPO use on cervical ripening in low-risk women with term pregnancy. Patients and Methods: Low-risk term pregnant women referred to the obstetrics clinic of Imam Hossein Hospital in Tehran who were eligible according to the inclusion, were randomized either to the case or control group. The case group received 1000 mg vaginal EPO capsule, and the other group received a vaginal placebo capsule daily, similar to the original drug. The primary outcome was Bishop score, while the duration of labor phases, and the inducing procedures were the secondary outcomes. Results: 48 participants were randomized to each group and were considered for data analysis. Although Bishop score was not statistically different before the intervention, it was significantly higher in case group compared to the placebo group after the intervention (EPO= 5.83 ± 1.68, placebo= 5.19 ± 1.52, p-value= 0.002). Four participants in the case group and 2 in the control group underwent cesarean section (p-value= 0.677). The need for labor induction was significantly higher in the placebo group than EPO group (Oxytocin injection: 10.4% vs 31.3%, p-value= 0.012, Amniotomy: 75% vs 41.7, p-value= 0.001). Conclusion: The vaginal use of EPO could be considered as a safe and efficient approach for cervical ripening in low-risk term pregnant women.

integrative & complementary medicine
Comparison of the effects of low doses of dexmedetomidine and remifentanil on the maternal hemodynamic changes during caesarean delivery in patients with severe preeclampsia: a randomized trial

Mohamed R El-Tahan,Samah El Kenany,Ehsan M Abdelaty,Eiad A Ramzy

DOI: https://doi.org/10.23736/S0375-9393.18.12312-1

Abstract:Background: Preoperative remifentanil administration blunts hemodynamic responses to tracheal intubation in parturients with severe preeclampsia. We hypothesized that the preoperative administration of low doses of remifentanil or dexmedetomidine would lead to comparable maternal neurohormonal responses and neonatal outcomes in patients with severe preeclampsia. Methods: Parturients diagnosed with severe preeclampsia undergoing caesarean delivery were randomLy allocated to receive remifentanil (0.1 µg/kg/min) or dexmedetomidine (0.4 µg/kg/h) at five min and 20 min before induction, respectively. Changes in maternal mean arterial BP(MAP), clinical recovery, cortisol level, and neonatal outcome, were recorded. Results: Patients who received remifentanil had higher response in MAP at the induction (94 9.8 vs. 104 4.5; P<0.001) and emergence from anesthesia (94 6.3 vs. 98 5.1; P<0.001), but shorter times to extubation (5.1 1.6 vs. 13.5 2.8 min; P<0.001). Five (27.8%) patients in the remifentanil group received ephedrine versus none in the dexmedetomidine group (P=0.023). The maternal plasma cortisol levels, the neonatal Neurologic and Adaptative Capacity Scores and acid-base satuses were similar in the two groups. Newborns in the remifentanil group presented lower Apgar scores at 1 minute (5.11 0.8 vs. 5.68 0.8; P=0.034) and a higher incidence of respiratory depression (72.2% vs. 36.8% P=0.048). Conclusions: Compared with dexmedetomidine (0.4 µg/kg/h), the preoperative administration of remifentanil (0.1 µg/kg/min) produced a significantly higher effect on maternal hemodynamic responses to caesarean delivery in patients with severe preeclampsia, however maternal hypotension and neonatal respiratory depression were more common with the use of remifentanil.
Treatment of impotence due to perineal venous leakage by ligation of crura penis.

O. Bar-Moshé,M. Vandendris

DOI: https://doi.org/10.1016/S0022-5347(17)42865-5

1988-06-01

Abstract:
Randomized Trial of the Effect of Drugs on Cervical Dilatation for Termination of First Trimester Pregnancy

DZ XU,MF LI,XM WU,LS LI,QL MA,QL FANG,HY ZHANG,GY LI

DOI: https://doi.org/10.1016/s0010-7824(09)91011-3

IF: 3.051

1990-01-01

Contraception

Abstract:A randomized triple-blind and placebo-controlled clinical trial on the effect of lidocaine and Anodyne-lubricant jelly (ALJ) containing dicaine on cervical dilatation is reported. Three-hundred-seventy-two consecutive cases were randomly allocated to 4 groups. The four groups were given: ALJ and placebo (placebo 1); and lidocaine and placebo (placebo 2). ALJ and placebo 1 treatment was by topical application, and lidocaine and placebo 2 by injection. In parous women, a significant difference was found for satisfactory dilatation (SD) rate (p less than 0.01) among four groups. It was unexpected that there were no significant differences between drug and placebo groups, neither between ALJ treatment group and placebo 1 group (p greater than 0.5), nor between lidocaine and placebo 2 (p greater than 0.75). However, the combined SD rate was 60.9% for the topical groups compared with 39.0% for the injection groups (p less than 0.005). The findings suggested that the effect of ALJ on cervical dilatation was not mainly due to dicaine, but associated with the lubricant and the topical treatment.

The effects of tobacco smoking on gastric motility in patients with duodenal ulcer.

A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia–Induced Hypotension During Cesarean Delivery

Comparative Dose-Response Study of Phenylephrine Bolus for the Treatment of the First Episode of Spinal Anesthesia-Induced Hypotension for Cesarean Delivery in Severe Preeclamptic Versus Normotensive Parturients

128: THE EFFECT OF INTRAMUSCULAR HYOSCINE AND HYOSCINE-PROMETHAZINE ON THE DURATION OF LABOR IN NULLIPAROUS PREGNANT WOMEN (TRIPLE-BLIND RANDOMIZED CONTROLLED TRIAL)

Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis

Effect of Ephedrine Combined with Bupivacaine on Maternal Hemodynamic and Spinal Nerve Block in Cesarean Delivery

Comparing the effect of intravenous dexamethasone, intravenous ondansetron, and their combination on nausea and vomiting in cesarean section with spinal anesthesia

Comparing the Effectiveness of Ondansetron and Dexamethasone on Nausea/Vomiting in Cesarean Section under Spinal Anesthesia

Adjuvant Treatment with Oral Dydrogesterone in the Prevention of Preterm Labor: A Randomized, Double-Blinded, Placebo-Controlled Trial

EFFECT OF LIDOCAINE ON CERVICAL MUCOSAL ABSORPTION ON LABOR PROGRESS AND EVALUATION OF ITS EFFECT

The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial

Effects of dicaine, valium combined anisodamine in induced labor of term pregnancy

Cost-effectiveness of clozapine therapy for severe psychosis.

Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4.

Comparison of the Prophylactic Effect of Propofol, Dexamethasone and Ondansetron on Post-Operative Nausea and Vomiting in Elective Cesarean Section Under Spinal Anesthesia

Efficacy of dexmedetomidine in suppressing cardiovascular and hormonal responses to general anaesthesia for caesarean delivery: a dose-response study

Comparing prophylactic effect of dexamethasone alone Vs combination of dexamethasone and ondansetron on nausea and vomiting in pregnant women undergoing cesarean section: A systematic review and meta-analysis of published randomized controlled trials

The Use of Evening Primrose Oil for Cervical Ripening in Low-Risk Women with Term Pregnancy: A Randomized Double-Blinded Controlled Trial

Comparison of the effects of low doses of dexmedetomidine and remifentanil on the maternal hemodynamic changes during caesarean delivery in patients with severe preeclampsia: a randomized trial

Treatment of impotence due to perineal venous leakage by ligation of crura penis.

Randomized Trial of the Effect of Drugs on Cervical Dilatation for Termination of First Trimester Pregnancy